Catalent | CTLT - Current Assets


Catalent reported $2.92B in Current Assets for its fiscal quarter ending in June of 2025.



Current Assets Change Date
Agilent USD 4.62B 21M Dec/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Bruker USD 2.21B 138.1M Dec/2025
Centene USD 40.37B 3.69B Dec/2025
Charles River Laboratories USD 1.45B 85.06M Dec/2025
Cigna USD 47.81B 1.08B Dec/2025
Danaher USD 12.76B 3.15B Dec/2025
Dentsply International USD 2.02B 49M Dec/2025
Elevance Health USD 63B 777M Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Glaxosmithkline GBP 23.98B 6.31B Sep/2025
Hologic USD 3.84B 175.3M Dec/2025
Humana USD 32.73B 19M Dec/2025
Illumina USD 3.29B 493M Dec/2025
Intuitive Surgical USD 12.4B 927.3M Dec/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Laboratory Of America USD 4.02B 58.3M Dec/2025
Lonza CHF 5.44B 113M Dec/2024
McKesson USD 59.7B 190M Dec/2025
Merck EUR 13.23B 354M Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Mettler Toledo International USD 1.36B 81.46M Dec/2025
Novartis USD 28.2B 2.26B Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Quest Diagnostics USD 2.38B 29M Dec/2025
Repligen USD 1.14B 40.9M Dec/2025
Revvity USD 2.24B 95.96M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Supernus Pharmaceuticals USD 644.18M 50.29M Dec/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
UnitedHealth USD 95.07B 1.37B Sep/2025
Veradigm USD 810.77M 18M Sep/2022
Waters USD 1.99B 69.86M Dec/2025
West Pharmaceutical Services USD 1.98B 154.9M Dec/2025